GlaxoSmithKline

GSK attracts negative rating news coverage as analysts turn bearish on stock

Posted on Updated on

Analysts’ bearish stance on GSK weighs on stock price heavily

Media coverage for GlaxoSmithKline Plc, one of the world’s largest drug makers was dominated by Stock Rating related news items in the past 90-days. FiND, an alternative data platform showed the underlying news sentiment for analyst rating coverage on GSK was mostly negative during this period (Image 1).

FiND offers high-end Media analytics by tracking mainstream news and social media in real-time and analyzing movement in underlying sentiment around it for all listed and unlisted companies across the globe.

GSK RATINGS COVERAGE - Part 1
Image 1: GSK – Top Topics and Ratings News Sentiment

Read the rest of this entry »